Folate‐caged PROTACs are a new subgroup of targeted protein degraders, consisting of folic acid (FA‐) moieties and designed to take advantage of the overexpression of folate receptors (FRs), particularly folate receptor alpha (FRα), on the plasma membranes of numerous tumor cells (Liu, Chen, Liu et al. 2021). The gene discussed is FOLR1; the disease is neoplasm.